Literature DB >> 34402895

Sex Differences in Cancer Genomes: Much Learned, More Unknown.

Chenghao Zhu1,2,3,4, Paul C Boutros1,2,3,4.   

Abstract

Cancer is a leading cause of death worldwide. Sex influences cancer in a bewildering variety of ways. In some cancer types, it affects prevalence; in others, genomic profiles, response to treatment, or mortality. In some, sex seems to have little or no influence. How and when sex influences cancer initiation and progression remain a critical gap in our understanding of cancer, with direct relevance to precision medicine. Here, we note several factors that complicate our understanding of sex differences: representativeness of large cohorts, confounding with features such as ancestry, age, obesity, and variability in clinical presentation. We summarize the key resources available to study molecular sex differences and suggest some likely directions for improving our understanding of how patient sex influences cancer behavior.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cancer; cancer genomics; genomics; sex difference

Mesh:

Year:  2021        PMID: 34402895      PMCID: PMC8439393          DOI: 10.1210/endocr/bqab170

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   5.051


  90 in total

Review 1.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

Review 2.  Thyroid cancer gender disparity.

Authors:  Reza Rahbari; Lisa Zhang; Electron Kebebew
Journal:  Future Oncol       Date:  2010-11       Impact factor: 3.404

3.  Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors.

Authors:  Markus Joerger; Alwin D R Huitema; Desiree H J G van den Bongard; Jan H M Schellens; Jos H Beijnen
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

4.  Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.

Authors:  Mirian Brink; Matty P Weijenberg; Anton F P M de Goeij; Guido M J M Roemen; Marjolein H F M Lentjes; Adriaan P de Bruïne; Manon van Engeland; R Alexandra Goldbohm; Piet A van den Brandt
Journal:  Int J Cancer       Date:  2005-05-01       Impact factor: 7.396

5.  Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial.

Authors:  B N Stein; N J Petrelli; H O Douglass; D L Driscoll; G Arcangeli; N J Meropol
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

6.  Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry.

Authors:  N A Dobbs; C J Twelves; H Gillies; C A James; P G Harper; R D Rubens
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 7.  Body mass index and mortality in heart failure: a meta-analysis.

Authors:  Antigone Oreopoulos; Raj Padwal; Kamyar Kalantar-Zadeh; Gregg C Fonarow; Colleen M Norris; Finlay A McAlister
Journal:  Am Heart J       Date:  2008-07       Impact factor: 4.749

8.  Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC.

Authors:  Anne M J Gilsing; Fiona Fransen; Theo M de Kok; Alexandra R Goldbohm; Leo J Schouten; Adriaan P de Bruïne; Manon van Engeland; Piet A van den Brandt; Anton F P M de Goeij; Matty P Weijenberg
Journal:  Carcinogenesis       Date:  2013-08-27       Impact factor: 4.944

9.  Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysis.

Authors:  Christopher J D Wallis; Mohit Butaney; Raj Satkunasivam; Stephen J Freedland; Sandip P Patel; Omid Hamid; Sumanta K Pal; Zachary Klaassen
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

10.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

View more
  2 in total

1.  Characterising sex differences of autosomal DNA methylation in whole blood using the Illumina EPIC array.

Authors:  Olivia A Grant; Yucheng Wang; Meena Kumari; Nicolae Radu Zabet; Leonard Schalkwyk
Journal:  Clin Epigenetics       Date:  2022-05-14       Impact factor: 7.259

Review 2.  PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases.

Authors:  Ke Zhang; Xiangyi Kong; Yuan Li; Zhongzhao Wang; Lin Zhang; Lixue Xuan
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.